Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularAdvances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularPracticing pathology in the era of big data and personalized medicineA retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung.De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancerClinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma.Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysisMutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.Cytology nomenclature and 2015 World Health Organization classification of lung cancer.Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.[Novel morphological and molecular aspects of lung cancer].Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study.Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.ALK fusion and its association with other driver gene mutations in Finnish non-small cell lung cancer patients.
P2860
Q26828860-6F35A2FB-C32E-4C53-B761-ED59BF2D77A5Q27009370-BDDC473B-E597-48CB-9B41-57C990A99421Q34159011-77D468AC-A1B8-474D-ACFD-42989A42EB6DQ34388847-CD8FD3F0-7E3D-4F28-B5EA-CB1B6D3BD7CFQ34585228-ECBFE154-AF78-4C5B-A916-F84D94272662Q35164473-459C6EE9-B0A3-45A6-A3D8-DE0465E1FA79Q35238397-5AD987C5-9FE5-4B86-9AF0-172866AC1677Q35679386-158E2FEB-DA6D-43FB-A7B8-55B5CE1E5959Q35957585-5A2A8B34-D6AE-42A1-916A-56D1DD2D6CEDQ36355858-465FFB37-4970-4F1E-B47D-1872EF247C1EQ37067360-2C5BCEC1-A484-4464-85DA-7B44DF8BAA95Q38606005-D3CF72E6-B509-4C81-BBFA-20E3D38539ADQ39934413-6233EDAA-ABC3-4F00-8CEF-5EF5AD0B4B8FQ40256906-D4DBEF5E-E1C9-4240-A853-331BA655691DQ41637380-721A7616-6ED3-4276-A0D7-A7167905C518Q42256127-7A94A42D-B5FC-4957-BE3A-9797437D2DCFQ45264604-8EB2134F-9286-4616-AE09-45CFDB18858AQ45276482-970E2CEC-68C2-48E7-80D3-6FF11071E908Q47117925-D8DD55D5-C944-45BA-A01E-135B5C9A8105Q48105860-BFAD512B-D7C7-41DE-B00A-8F613A991457Q55073653-C8D14282-B315-41BC-8E5E-F15EC2EC37C4
P2860
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@ast
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@en
type
label
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@ast
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@en
prefLabel
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@ast
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@en
P2093
P2860
P1433
P1476
Distinct profile of driver mut ...... ulmonary large-cell carcinoma.
@en
P2093
Agnes Colanta
Andre L Moreira
Camelia S Sima
Jamie E Chaft
Laura J Tafe
Maria E Arcila
Mark G Kris
Maureen F Zakowski
Natasha Rekhtman
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.195
P50
P577
2012-11-30T00:00:00Z
P5875
P6179
1052329940